Erythromycin, anhydro-, N-oxide
(2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-N,N,6-trimethyloxan-4-amine oxide
Also Known As: Erythromycin A N-oxide|Erythromycin, N-oxide|Erythromycin, anhydro-, N-oxide|Anhydroerythromycin-N-oxide|Erythromycin EP Impurity H|Erythromycin,N-oxide|USAF EL-99|Erythromycin A N-oxide (>80%)|KST-1A0237|ERYTHROMYCIN A 3''-N-OXIDE|ERYTHROMYCIN IMPURITY H [EP IMPURITY]|Erythromycin EP Impurity HErythromycin A N-oxide|ERYTHROMYCIN EP IMPURITY H (REFERENCE GRADE)|(2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-N,N,6-trimethyloxan-4-amine oxide|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-{[(2s,3r,4s,6r)-4-(dimethylnitroryl)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione(non-preferred name)|(2S,3R,4S,6R)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-3-hydroxy-N,N,6-trimethyltetrahydro-2H-pyran-4-amine oxide|(2S,3R,4S,6R)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl)oxy)-3-hydroxy-N,N,6-trimethyloxan-4-amine oxide|(2S,3R,4S,6R)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-Ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradecan-6-yl]oxy}-3-hydroxy-N,N,6-trimethyloxan-4-amine N-oxide|Erythromycin, N-oxide; Oxacyclotetradecane, erythromycin deriv.; Erythromycin A N-oxide; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-ss-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione N-Oxide; Erythromycin A 3''-N-Oxide
| Molecular Formula | C37H67NO14 |
|---|---|
| Molecular Weight | 749.4562 g/mol |
| LogP | 1.8 |
| Topological Polar Surface Area | 213.73 Ų |
| Hydrogen Bond Donors | 5 |
| Hydrogen Bond Acceptors | 14 |
| Rotatable Bonds | 7 |
| Exact Mass | 749.4562 |
| Heavy Atoms | 52 |
| Complexity | 1209.3 |
Chemical Identifiers
| CAS Number | 992-65-4 |
|---|---|
| SMILES | CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[N+](C)(C)[O-])O)(C)O)C)C)O)(C)O |
Product Overview
Erythromycin, anhydro-, N-oxide (CAS 992-65-4), with molecular formula C37H67NO14 and molecular weight 749.4562 g/mol. IUPAC: (2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-N,N,6-trimethyloxan-4-amine oxide.
Frequently Asked Questions
📚 Academic Support
Scientific research papers and technical documentation supporting this product for informed procurement decisions.
Technical Blog Article
Multi-source research profile: chemical properties, regulatory status, and sourcing guide for Erythromycin, anhydro-, N-oxide.
Browse Technical Blog →No research papers found for this product yet.
We continuously update our academic references. Check back soon!